174 related articles for article (PubMed ID: 16221220)
1. N-acetylcysteine attenuates the progression of chronic renal failure.
Shimizu MH; Coimbra TM; de Araujo M; Menezes LF; Seguro AC
Kidney Int; 2005 Nov; 68(5):2208-17. PubMed ID: 16221220
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
Nitescu N; Ricksten SE; Marcussen N; Haraldsson B; Nilsson U; Basu S; Guron G
Nephrol Dial Transplant; 2006 May; 21(5):1240-7. PubMed ID: 16390850
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
Shimizu MH; Danilovic A; Andrade L; Volpini RA; Libório AB; Sanches TR; Seguro AC
Nephrol Dial Transplant; 2008 Oct; 23(10):3067-73. PubMed ID: 18469310
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine protects rats with chronic renal failure from gadolinium-chelate nephrotoxicity.
Pereira LV; Shimizu MH; Rodrigues LP; Leite CC; Andrade L; Seguro AC
PLoS One; 2012; 7(7):e39528. PubMed ID: 22815709
[TBL] [Abstract][Full Text] [Related]
5. Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet.
Wesson DE; Simoni J
Kidney Int; 2010 Dec; 78(11):1128-35. PubMed ID: 20861823
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
Bianchi S; Bigazzi R; Campese VM
Kidney Int; 2006 Dec; 70(12):2116-23. PubMed ID: 17035949
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
Brown NJ; Nakamura S; Ma L; Nakamura I; Donnert E; Freeman M; Vaughan DE; Fogo AB
Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
[TBL] [Abstract][Full Text] [Related]
8. Influence of ferulic acid on nicotine-induced lipid peroxidation, DNA damage and inflammation in experimental rats as compared to N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Devaraj H; Menon VP
Toxicology; 2008 Jan; 243(3):317-29. PubMed ID: 18068289
[TBL] [Abstract][Full Text] [Related]
9. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure.
de Araujo M; Andrade L; Coimbra TM; Rodrigues AC; Seguro AC
J Am Soc Nephrol; 2005 Nov; 16(11):3339-49. PubMed ID: 16177005
[TBL] [Abstract][Full Text] [Related]
10. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.
Mejía-Vilet JM; Ramírez V; Cruz C; Uribe N; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F78-86. PubMed ID: 17376767
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1.
Machado JT; Iborra RT; Fusco FB; Castilho G; Pinto RS; Machado-Lima A; Nakandakare ER; Seguro AC; Shimizu MH; Catanozi S; Passarelli M
Atherosclerosis; 2014 Nov; 237(1):343-52. PubMed ID: 25305669
[TBL] [Abstract][Full Text] [Related]
12. Role of aldosterone in the remnant kidney model in the rat.
Greene EL; Kren S; Hostetter TH
J Clin Invest; 1996 Aug; 98(4):1063-8. PubMed ID: 8770880
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and prevents oxidative stress in uremic rats.
Michea L; Villagrán A; Urzúa A; Kuntsmann S; Venegas P; Carrasco L; Gonzalez M; Marusic ET
Hypertension; 2008 Aug; 52(2):295-300. PubMed ID: 18591458
[TBL] [Abstract][Full Text] [Related]
14. Effect of spironolactone on hypertrophy of left ventricular myocardium in wistar rats with experimental uremia.
Karabayeva AZh; Esaian AM; Kayukov IG; Parastaeva MM; Beresneva ON; Kotenko LV; Sevastyanova IE
Bull Exp Biol Med; 2008 Jun; 145(6):714-6. PubMed ID: 19110558
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
Seguro AC; Poli de Figueiredo LF; Shimizu MH
J Surg Res; 2012 Jun; 175(2):312-5. PubMed ID: 21764077
[TBL] [Abstract][Full Text] [Related]
16. The effect of N-acetylcysteine on pulmonary lipid peroxidation and tissue damage.
Akca T; Canbaz H; Tataroglu C; Caglikulekci M; Tamer L; Colak T; Kanik A; Bilgin O; Aydin S
J Surg Res; 2005 Nov; 129(1):38-45. PubMed ID: 16243047
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.
Miric G; Dallemagne C; Endre Z; Margolin S; Taylor SM; Brown L
Br J Pharmacol; 2001 Jul; 133(5):687-94. PubMed ID: 11429393
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats.
Nielsen FT; Jensen BL; Marcussen N; Skøtt O; Bie P
Nephrol Dial Transplant; 2008 Sep; 23(9):2777-83. PubMed ID: 18424460
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine prevents pulmonary edema and acute kidney injury in rats with sepsis submitted to mechanical ventilation.
Campos R; Shimizu MH; Volpini RA; de Bragança AC; Andrade L; Lopes FD; Olivo C; Canale D; Seguro AC
Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L640-50. PubMed ID: 22268121
[TBL] [Abstract][Full Text] [Related]
20. Role of 11beta-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure.
Yeyati NL; Altuna ME; Damasco MC; Mac Laughlin MA
Braz J Med Biol Res; 2010 Jan; 43(1):52-6. PubMed ID: 20027486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
